These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21544515)

  • 1. Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice.
    Lin GJ; Huang SH; Chen YW; Hueng DY; Chia WT; Chien MW; Yen BL; Sytwu HK
    Diabetologia; 2011 Jul; 54(7):1777-87. PubMed ID: 21544515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.
    Huang SH; Chu CH; Yu JC; Chuang WC; Lin GJ; Chen PL; Chou FC; Chau LY; Sytwu HK
    Diabetologia; 2010 Nov; 53(11):2389-400. PubMed ID: 20683574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.
    Cameron MJ; Arreaza GA; Grattan M; Meagher C; Sharif S; Burdick MD; Strieter RM; Cook DN; Delovitch TL
    J Immunol; 2000 Jul; 165(2):1102-10. PubMed ID: 10878389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice.
    Hultcrantz M; Jacobson S; Hill NJ; Santamaria P; Flodström-Tullberg M
    Diabetologia; 2009 Feb; 52(2):299-305. PubMed ID: 19031069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
    Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
    Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
    Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.
    Serreze DV; Chapman HD; Varnum DS; Hanson MS; Reifsnyder PC; Richard SD; Fleming SA; Leiter EH; Shultz LD
    J Exp Med; 1996 Nov; 184(5):2049-53. PubMed ID: 8920894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.
    Berres ML; Trautwein C; Zaldivar MM; Schmitz P; Pauels K; Lira SA; Tacke F; Wasmuth HE
    Biol Chem; 2009 Oct; 390(10):1039-45. PubMed ID: 19642876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.
    Ziegler AI; Le Page MA; Maxwell MJ; Stolp J; Guo H; Jayasimhan A; Hibbs ML; Santamaria P; Miller JF; Plebanski M; Silveira PA; Slattery RM
    Diabetologia; 2013 Dec; 56(12):2659-68. PubMed ID: 24013782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses.
    Meagher C; Arreaza G; Peters A; Strathdee CA; Gilbert PA; Mi QS; Santamaria P; Dekaban GA; Delovitch TL
    Diabetes; 2007 Mar; 56(3):809-17. PubMed ID: 17327452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
    Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
    Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice.
    Carvalho-Pinto C; García MI; Gómez L; Ballesteros A; Zaballos A; Flores JM; Mellado M; Rodríguez-Frade JM; Balomenos D; Martínez-A C
    Eur J Immunol; 2004 Feb; 34(2):548-57. PubMed ID: 14768060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse.
    Solomon M; Balasa B; Sarvetnick N
    Autoimmunity; 2010 Mar; 43(2):156-63. PubMed ID: 19824873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.